AzTrials
AzTrials

Osteo Arthritis Knee and HipNCT07383740

Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis

A study testing Submaximal cycle ergometer test-retest in people with Osteo Arthritis Knee and Hip, run by Vastra Gotaland Region at 1 site in Sweden.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA). Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. Read more about this study

Who is it for?
Ages 30 years and older
Conditions the study is for
Osteo Arthritis Knee and Hip
What is being tested?
Submaximal cycle ergometer test-retest
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSweden
Study dates
21 Apr 2026to 1 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Currently listed on the waiting list for an osteoarthritis rehabilitation program due to clinically diagnosed hip and/or knee osteoarthritis.

Who cannot join

  • Another primary cause of symptoms or disability, such as inflammatory joint disease or fracture.
  • Another condition currently causing more symptoms than osteoarthritis, for example fibromyalgia.
  • Insufficient understanding of written and spoken Swedish.
  • Medication that affects heart rate.
  • Contraindications for a submaximal ergometer bicycle test according to the screening protocol, such as heart disease.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Daniel Karsberg Zotterman, MSc contact

+46739298119

daniel.karsberg.zotterman@vgregion.se

Stefan Lundqvist, PhD contact

+46762276179

stefan.lundqvist@vgregion.se

Sweden1 site, 1 recruiting
  • Närhälsan Gibraltar Rehab

    Gothenburg

    Daniel Karsberg Zotterman, +46702273688, daniel.karsberg.zotterman@vgregion.se

    Recruiting

Other trials in Sweden

About this study

Official title: Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip- and/or Knee Osteoarthritis

The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA).

Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks.

Read more

The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA.

To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.

Being tested
Submaximal cycle ergometer test-retest
Keywords
Osteoarthritis, knee osteoarthritis, hip osteoarthritis, exercise test, reliability, cardiorespiratory fitness, test-retest
Medical subject headings
Osteoarthritis, Osteoarthritis, Knee, Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Submaximal cycle ergometer test-retestProcedure or surgery

    Performing a submaximal cycle ergometer test twice

Study groups in NCT07383740
Study groupRoleWhat they receive
Forty patients with osteoarthritis in hip or kneeExperimentalForty patients with hip or knee osteoarthritis on the waiting list for usual rehabilitation care will be recruited. The patientes will be screened for contraindications, and, if eligible, will complete a submaximal cycle ergometer test twice within one week.
Receives: Procedure: Submaximal cycle ergometer test-retest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Estimated VO2-max value.

    An estimated VO2-max value is obtained by performing the Ekblom Bak submaximal cycle ergometer test.

    Measured: Time between first and second submaximal cycle ergometer test should be one week.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Feb 2026
  2. Study start21 Apr 2026
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
Test-retest reliability of a submaximal cycle ergometer test.
Masking
None (open label)
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07383740
Sponsor's protocol ID
Test-retest_adapted_EB
Status last verified
Jan 2026
First submitted
19 Jan 2026
Last updated
20 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Submaximal cycle ergometer test-retest in people with Osteo Arthritis Knee and Hip, run by Vastra Gotaland Region at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Daniel Karsberg Zotterman, MSc (+46739298119, daniel.karsberg.zotterman@vgregion.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Estimated VO2-max value. (time frame: Time between first and second submaximal cycle ergometer test should be one week.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in